journal
Journals Journal der Deutschen Dermatol...

Journal der Deutschen Dermatologischen Gesellschaft : JDDG

https://read.qxmd.com/read/38032225/pre-test-probability-of-sexually-transmitted-infections-in-persons-presenting-to-a-sti-clinic-a-prospective-study
#1
LETTER
Birgit Sadoghi, Florian Posch, Peter Komericki, Katharina Tripolt-Droschl, Birger Kränke, Sasha A Ahyai, Tanja Strimitzer-Komericki, Georg C Hutterer
No abstract text is available yet for this article.
November 30, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38009460/long-term-remission-with-rituximab-therapy-in-a-five-year-old-patient-with-pemphigus-vulgaris
#2
LETTER
Bilgen Erdoğan, Elif Nur Meral, Zeynep Topkarci, Nevin Hatipoğlu, Ayşe Kavak
No abstract text is available yet for this article.
November 27, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37984855/geographic-tongue-what-is-this-disease
#3
REVIEW
Yasuhiro Horiuchi
Geographic tongue or benign migratory glossitis, is a unique and peculiar tongue condition, producing a map-like appearance with filiform papillae atrophy, on different parts of the tongue. The lesions change in shape with time. The exact etiology remains unknown, although it has been suggested relating the lingual microbiota of a patient. The association between geographic tongue and psoriasis has long been pointed out, and histological similarities existed between both as well. Increasingly, recent findings suggest the involvement of certain oral bacteria...
November 20, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37953404/vexas-syndrome-a-newly-described-autoinflammatory-systemic-disease-with-dermatologic-manifestations
#4
REVIEW
Vera Baur, Johanna Stoevesandt, Axel Hueber, Ulrike Hüffmeier, Hermann Kneitz, Henner Morbach, Erwin Schultz, Matthias Goebeler
VEXAS syndrome is a recently identified autoinflammatory systemic disease caused by an acquired somatic mutation of the X-linked UBA1 gene, the key enzyme of the first step of ubiquitylation. The acronym VEXAS stands for the characteristics Vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic. The disease occurs in advanced adulthood preferentially in men and is characterized by hematological, rheumatological and dermatological symptoms. The latter include neutrophil-rich lesions reminiscent of Sweet's syndrome, erythema nodosum- and panniculitis-like skin manifestations and recurrent polychondritis of the nose and auricles...
November 12, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37946629/a-three-dimensional-a-t-flap-for-repairing-full-thickness-defect-of-the-eyelid-margin
#5
JOURNAL ARTICLE
Xian Yan Luo, Ai E Xu
No abstract text is available yet for this article.
November 9, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37940570/five-years-follow-up-of-a-patient-with-porokeratosis-ptychotropica-and-mvk-gene-mutation
#6
LETTER
Mihail-Alexandru Badea, Alin-Laurentiu Tatu, Mina Saleva-Stateva, Cristina Has
No abstract text is available yet for this article.
November 8, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37926837/black-purplish-nodules-on-skin-a-time-sensitive-finding
#7
Alvaro Prados-Carmona, Alexandra Remón-Love, Ricardo Ruiz-Villaverde
No abstract text is available yet for this article.
November 5, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37926830/drug-survival-and-clinical-effectiveness-of-secukinumab-ixekizumab-brodalumab-guselkumab-risankizumab-tildrakizumab-for-psoriasis-treatment
#8
JOURNAL ARTICLE
Luca Mastorino, Paolo Dapavo, Sara Susca, Caterina Cariti, Niccolò Siliquini, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Pietro Quaglino, Simone Ribero
BACKGROUND: Biologics targeting IL-23 and IL-17 show efficacy and safety in the treatment of moderate-to-severe psoriasis. OBJECTIVE: To investigate drug survival in patients with psoriasis treated with biologics. PATIENTS AND METHODS: We performed a comparative evaluation of the achievement of PASI 90 and PASI ≤ 3 at 16, 28, and 52 weeks along with a DS (drug survival) analysis with IL-17 and IL-23 inhibitors brodalumab, ixekizumab, secukinumab, risankizumab, tildrakizumab, and guselkumab on 1,057 patients...
November 5, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37919045/a-crusted-ulcer-of-the-nipple
#9
Andrea Michelerio, Carlo Tomasini
No abstract text is available yet for this article.
November 2, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37907427/evolution-of-characteristics-and-biologic-treatment-effectiveness-in-patients-of-the-austrian-psoriasis-registry-from-2004-2022
#10
JOURNAL ARTICLE
Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, Wolfgang Weger, Claudia Zikeli, Barbara Gruber, Paul Sator, Knut Prillinger, Alexander Mlynek, Martina Schütz-Bergmayr, Leo Richter, Gudrun Ratzinger, Christoph Sassmann, Clemens Painsi, Nina Häring, Katharina Wippel-Slupetzky, Hans Skvara, Hannes Trattner, Martin Inzinger, Christina Bangert, Christina Ellersdorfer, Katharina Falkensteiner, Birgit Sadoghi, Alexandra Gruber-Wackernagel, Angelika Hofer, Franz Legat, Bernhard Lange-Asschenfeldt, Matthias Schmuth, Igor Vujic, Wolfram Hötzenecker, Werner Saxinger, Robert Müllegger, Franz Quehenberger, Peter Wolf
BACKGROUND AND OBJECTIVES: This study analyzed the extent to which the recent introduction of more effective treatments has led to an improvement in real-world psoriasis patients. PATIENTS AND METHODS: Patient characteristics and the first-year treatment effectiveness in biologic-naive patients have been analyzed since 2004 until now, irrespective of treatment switches. RESULTS: Data from 2,729 patients were eligible for this analysis. The proportion of female patients increased significantly over the years from 29...
October 31, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37902386/identifying-biomarkers-and-novel-therapeutic-targets-in-uveal-melanoma
#11
REVIEW
Anja Wessely, Elias A T Koch, Julio Vera, Carola Berking, Markus V Heppt
Uveal melanoma (UM) is an orphan cancer despite being the most common eye tumor in adults. Patients often present to skin cancer centers for treatment of metastatic disease although there are significant genetic, biological, and clinical differences from cutaneous melanoma. The treatments most commonly used for metastatic UM are tebentafusp and combined immune checkpoint blockade, both of which yield low response rates and may be accompanied by high treatment costs and significant immune-related toxicities...
October 30, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37884458/endothelial-and-tumor-intrinsic-mechanisms-of-hepatic-melanoma-metastasis
#12
REVIEW
Sebastian A Wohlfeil, Cyrill Géraud
The treatment of metastatic cutaneous melanoma was fundamentally improved by the discovery and introduction of immune checkpoint inhibitors, such as anti-PD-1 and anti-CTLA-4 antibodies, and targeted therapy with BRAF and MEK inhibition. Unfortunately, many patients suffer a relapse due to resistance mechanisms that in part are mediated by organ-specific metastatic sites. Especially, brain and liver metastases are negative predictive factors for both treatment modalities. There is still high unmet clinical need to prevent and treat spread to these organs...
October 26, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37875786/diagnostic-delay-comorbid-hidradenitis-suppurativa-and-the-prognostic-value-of-bacterial-culture-in-folliculitis-decalvans-a-cohort-study
#13
JOURNAL ARTICLE
Anna Lyakhovitsky, Oz Segal, Eran Galili, Curtis T Thompson, Ido Tzanani, Alon Scope, Sharon Baum, Aviv Barzilai
BACKGROUND: Folliculitis decalvans (FD) is a type of primary neutrophilic cicatricial alopecia often leading to irreversible hair loss. Data on its epidemiology, clinical features, outcomes, and prognostic factors are limited. OBJECTIVE: To evaluate a cohort of patients with FD and identify characteristics of severe disease and prognostic factors which impede remission. PATIENTS AND METHODS: This retrospective cohort study included 192 patients diagnosed with FD and followed for at least six months at a tertiary center between 2010 and 2020...
October 24, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37875785/modern-diagnostics-and-treatment-of-merkel-cell-carcinoma
#14
JOURNAL ARTICLE
Juliane Weilandt, Wiebke K Peitsch
Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with epithelial and neuroendocrine differentiation, the incidence of which has increased substantially during the last decades. Risk factors include advanced age, fair skin type, UV exposure, and immunosuppression. Pathogenetically, a type caused by the Merkel cell polyomavirus is distinguished from a UV-induced type with a high tumor mutational burden. Clinically, MCC presents as a mostly painless, rapidly growing, reddish-violet tumor with a shiny surface, which is preferentially localized in the head-neck region and at the distal extremities...
October 24, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37875784/a-nodule-on-the-nail-bed-with-nail-erosion
#15
Jingqiu Zhang, Xin Liu, Liang Zhang, Liuqing Chen
No abstract text is available yet for this article.
October 24, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37875783/refractory-iga-pemphigus-successfully-managed-with-adalimumab-as-monotherapy
#16
LETTER
Juan José Lluch-Galcerá, Carmen Alcoverro, Eugeni Prat, Manel Martinez-Molina, Isabel Bielsa, Ariadna Quer, Julio Bassas
No abstract text is available yet for this article.
October 24, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37875782/dupilumab-for-a-5-year-old-child-with-prurigo-nodularis
#17
LETTER
Lin Chia-Jen, Li Yun-Chang, Chang Hui-Chin, Hsiao Yu-Ping
No abstract text is available yet for this article.
October 24, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37857559/recurrent-large-perianal-plaque-conjunctivitis-erosive-stomatitis-penile-erosions-and-generalized-bullous-skin-lesions
#18
Esen Özkaya, Sevgi Kuzugüdenli, Ozgke Impram Ntousounous, Şule Öztürk Sarı
No abstract text is available yet for this article.
October 19, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37847912/disseminated-itching-papules-in-a-jamaican-patient
#19
Marisa Klemp, Björn Chapuy, Ann-Christin von Brünneck, Gabor Dobos, Rose K C Moritz
No abstract text is available yet for this article.
October 17, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/37847905/onychomadesis-following-pityriasis-lichenoides-et-varioliformis-acuta-treated-with-methotrexate
#20
LETTER
Lluís Corbella-Bagot, Andrea Combalia, Xavier Bosch-Amate
No abstract text is available yet for this article.
October 17, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
journal
journal
40361
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.